View Item 

Show simple item record

He reshaped the forefront of xenotransplantation: Agustin Pasqual Dalmasso (1933–2021)
dc.contributor.authorPlatt, Jeffrey L.
dc.contributor.authorVercellotti, Gregory M.
dc.date.accessioned2022-09-26T16:05:35Z
dc.date.available2023-08-26 12:05:34en
dc.date.available2022-09-26T16:05:35Z
dc.date.issued2022-07
dc.identifier.citationPlatt, Jeffrey L.; Vercellotti, Gregory M. (2022). "He reshaped the forefront of xenotransplantation: Agustin Pasqual Dalmasso (1933–2021)." Xenotransplantation 29(4): n/a-n/a.
dc.identifier.issn0908-665X
dc.identifier.issn1399-3089
dc.identifier.urihttps://hdl.handle.net/2027.42/174848
dc.description.abstractAgustin Pasqual Dalmasso died in December 2021. He was 88 years old and an Honorary Member of the International Xenotransplantation Association. Gus made seminal contributions to understanding and overcoming the barrier complement system poses to xenotransplantation. Those endeavoring to advance xenotransplantation to clinical application and those seeking the most topics in which to devote their life’s work could do no better than examining how Gus approached the subjects of his life’s work.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherCD55
dc.subject.otherCD59
dc.subject.othercomplement
dc.subject.othercomplement activation
dc.subject.othercomplement regulation
dc.subject.otherendothelial cells
dc.subject.otherthymus
dc.subject.otherxenotransplantation
dc.titleHe reshaped the forefront of xenotransplantation: Agustin Pasqual Dalmasso (1933–2021)
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNatural Resources and Environment
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/174848/1/xen12770.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/174848/2/xen12770_am.pdf
dc.identifier.doi10.1111/xen.12770
dc.identifier.sourceXenotransplantation
dc.identifier.citedreferenceVercellotti GM, Platt JL, Bach FH, Dalmasso AP. Enhanced neutrophil adhesion to xenogeneic endothelium via C3bi. J Immunol. 1991; 146: 730 – 734.
dc.identifier.citedreferenceMuller‐Eberhard HJ, Nilsson UR, Dalmasso AP, Polley MJ, Calcott MA. A molecular concept of immune cytolysis. Arch Pathol. 1966; 82: 205 – 217.
dc.identifier.citedreferenceCrist E, Tauber AI. Debating humoral immunity and epistemology: the rivalry of the immunochemists Jules Bordet and Paul Ehrlich. J Hist Biol. 1997; 30: 321 – 356.
dc.identifier.citedreferencePillemer L, Blum L, Lepow IH, Ross OA, Todd EW, Wardlaw AC. The properdin system and immunity: demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954; 120: 279 – 285.
dc.identifier.citedreferenceNelson RA, Jr. An alternative mechanism for the properdin system. J Exp Med. 1958; 108: 515 – 535.
dc.identifier.citedreferencePolley MJ, Müller‐Eberhard HJ. Chemistry and mechanism of action of complement. Prog Hematol. 1966; 5: 2 – 25.
dc.identifier.citedreferenceYachnin S, Ruthenberg JM. The initiation and enhancement of human red cell lysis by activators of the first component of complement and by first component esterase; studies using normal red cells and red cells from patients with paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1965; 44: 518 – 534.
dc.identifier.citedreferencePickering RJ, Wolfson MR, Good RA, Gewurz H. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A. 1969; 62: 521 – 527.
dc.identifier.citedreferenceGewurz H, Shin HS, Mergenhagen SE. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968; 128: 1049 – 1057.
dc.identifier.citedreferenceMarcus RL, Shin HS, Mayer MM. An alternate complement pathway: C‐3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; Relation to properdin. Proc Natl Acad Sci USA. 1971; 68: 1351 – 1354.
dc.identifier.citedreferenceLachmann PJ, Nicol P. Reaction mechanism of the alternative pathway of complement fixation. Lancet. 1973; 1: 465 – 467.
dc.identifier.citedreferenceHamad I, Hunter AC, Szebeni J, Moghimi SM. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP‐2‐dependent process. Mol Immunol. 2008; 46: 225 – 232.
dc.identifier.citedreferenceSilverstein AM. Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat Immunol. 2001; 2: 279 – 281.
dc.identifier.citedreferenceMeri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA. 1990; 87: 3982 – 3986.
dc.identifier.citedreferenceDonin N, Jurianz K, Ziporen L, Schultz S, Kirschfink M, Fishelson Z. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clin Exp Immunol. 2003; 131: 254 – 263.
dc.identifier.citedreferenceDalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol. 1992; 140: 1157 – 1166.
dc.identifier.citedreferenceDalmasso AP, He T, Benson BA. Human IgM xenoreactive antibodies can induce resistance of porcine endothelial cells to complement‐mediated injury. Xenotransplantation. 1996; 3: 54 – 62.
dc.identifier.citedreferenceDalmasso AP, Benson BA, Johnson JS, Lancto C, Abrahamsen MS. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1‐3)Gal binding lectin: up‐regulation of CD59 expression. J Immunol. 2000; 164: 3764 – 3773.
dc.identifier.citedreferencePlatt JL, Vercellotti GM, Lindman BJ, Oegema TR, Jr., Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med. 1990; 171: 1363 – 1368.
dc.identifier.citedreferenceCooper MD, Peterson RDA, Good RA. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature. 1965; 205: 143 –> 146.
dc.identifier.citedreferenceCooper MD, Gabrielsen AE, Good RA. Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med. 1967; 18: 113 – 139.
dc.identifier.citedreferenceMiller JF. The discovery of thymus function and of thymus‐derived lymphocytes. Immunol Rev. 2002; 185: 7 – 14.
dc.identifier.citedreferenceMiller JF. Immunological function of the thymus. Lancet. 1961; 2: 748 – 749.
dc.identifier.citedreferenceGood RA, Dalmasso AP, Martinez C, Archer OK, Pierce JC, Papermaster BW. The role of the thymus in development of immunologic capacity in rabbits and mice. J Exp Med. 1962; 116: 733 – 796.
dc.identifier.citedreferenceDalmasso AP, Martinez C, Sjodin K, Good RA. Studies on the role of the thymus in immunobiology; reconstitution of immunologic capacity in mice thymectomized at birth. J Exp Med. 1963; 118: 1089 – 1109.
dc.identifier.citedreferencePlatt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today. 1990; 11: 450 – 456.
dc.identifier.citedreferenceDalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement‐mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation. 1991; 52: 530 – 533.
dc.identifier.citedreferenceDalmasso AP, Mueller‐Eberhard HJ. Interaction of autologous complement with red cells in the absence of antibody. Proc Soc Exp Biol Med. 1964; 117: 643 – 650.
dc.identifier.citedreferenceDalmasso AP. On the intersections of basic and applied research in xenotransplantation. Xenotransplantation. 2012; 19: 137 – 143.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
xen12770.pdf
Size:
380.3KB
Format:
PDF
View/Open
Name:
xen12770_am.pdf
Size:
639.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.